This content was current as of the date it was released. In science and medicine, information is constantly changing and may become out-of-date as new data emerge.
I hope my US-based readers had a happy healthy holiday weekend. This past weekend, in addition to recovering from my Paris jetlag, I have been reading abstracts in preparation to travel to the European Hematology Association meeting next Monday in Copenhagen. The meeting doesn’t start until Thursday, but I’ll be presenting some preliminary data from our Reader Poll at a symposium on Wednesday. Thanks again to those participants for taking the time to participate.
This week in the Conference Coverage section of the CLL Society website, we’ve posted an interview from ASH 2015 with Dr. Anthony Mato out of the University of Pennsylvania. He, along with 9 other institutions gathered data about their patients who discontinued either ibrutinib or idelalisib. You can read about the study and watch my interview with Dr. Mato here.
From time to time, we will make you aware of in-person meetings coming up for those of us affected by CLL. In June, they include:
June 16th at 6 PM in Salt Lake City, UT: The Lymphoma Research Foundation will be hosting Updates on Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma as part of their Ask the Doctor series. You can find out more information and register here. There is no charge to attend.
In the meantime….
We are all in this together.
Brian Koffman, MD
Volunteer Medical Director of the CLL Society